Condition: Premenstrual Syndrome · Premenstrual Dysphoric Disorder · Dysmenorrhea · Sponsor: Samphire Group, Inc.
This study evaluates the feasibility and efficacy of the Samphire Guided Care (SGC) program * a 12-week structured digital health program combining clinician-led onboarding, at-home neuromodulation using the Lutea tDCS device, neuromodulation coach support, and app-based symptom tracking - on work productivity, employee wellbeing, and quality of life in individuals experiencing mood and cognitive symptoms associated with menstruation, perimenopause, or menopause.
This description comes directly from the study's public registry record.
Nirav Shah, MD, MPH · 6267201547 · nirav@investigator.alethios.com
Zeenia Framroze · support@alethios.com
Always discuss trial participation with your own doctor first.
| Alethios Digital Research Platform (Decentralized) | San Francisco, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07679074